When we stratified patients based on CALD1 expression, we observed a considerable difference in survival for patients suffering lower grade glioma (LGG—a cancer of the CNS, see Supplementary Table S4 for cross-referencing between cell lines and TCGA cancers and for the full names of cancer abbreviations), but not for patients with acute myeloid leukemia (LAML—a cancer of the blood, Fig. 6B left panel for LGG and right panel for LAML). This evidence concerns the gene CALD1 and hematopoietic and lymphoid system neoplasm.